by gastrointestinal polyposis and mucocutaneous pigmentation. PJS patients have an increased risk of cancer in multiple locations. Germ-line mutations in the STK11 gene have been found to be responsible for most PJS cases. DNA samples were obtained from a Chinese child with PJS, his clinically unaffected parents and 50 unrelated normal individuals, and the exons and flanking intronic sequences of the STK11 gene were analysed by polymerase chain reaction and direct sequencing. A novel de novo mutation (c.698_699insG; F234LfsX3) was identified in exon 5 of STK11, that resulted in a translational frameshift leading to termination at codon 236. This mutation was not found in the parents or unrelated individuals. These results enlarge the genotypic spectrum of STK11, particularly with regard to early onset, as observed in the present sporadic PJS case. This study may have important future implications for precise genotype-phenotype correlation research.
Introduction
Peutz-Jeghers syndrome (PJS; OMIM 175200) is a rare autosomal dominant inherited disorder characterized by gastrointestinal polyposis and mucocutaneous pigmentation of the lips, buccal mucosa and digits. 1,2 PJS patients have an increased risk of cancer at multiple sites, such as the gastrointestinal tract, pancreas, lung, breast and reproductive organs. 3 -5 Germline mutations in the serine/threonine kinase 11 (STK11) gene at 19p13.3 have been found to be responsible for most PJS cases. 6, 7 The gene spans 23 kilobases and has nine coding exons and a final non-coding exon. 6, 7 The protein it encodes plays a role in the p53-dependent apoptosis pathway, the vascular endothelial growth factor signalling pathway, cell polarization and cell energy metabolism. 8 -11 In the present study, a novel de novo STK11 mutation was identified in a Chinese child with PJS. This mutation was absent in both of the patient's parents. STK11 mutation in Peutz-Jeghers syndrome
Case report PATIENT
The proband was a 6-year-old Chinese boy who presented at 1.5 years of age with bloody stools and prolapse of a pedunculated polypoid mass as initial symptoms. He had undergone colonoscopy with polypectomy several times. Melanin pigmentation spots on the lips and buccal mucosa, which emerged gradually, were first noticed when he was 4 years old. Intermittent abdominal pain, melaena and/or bloody stools occurred from the age of 5 years. Intussusception was identified in the small bowel by exploratory laparotomy at 6 years. Endoscopy demonstrated multiple polyps throughout the gastrointestinal tract. Histopathological examination of the polyps at 6 years revealed hamartomatous polyps in the small intestine, tubular grade I adenoma in the gastric body, chronic inflammation with polypoid hyperplasia in the horizontal part of the duodenum and juvenile polyps in the ascending colon ( Fig.  1 ). His mother's pregnancy had been of normal duration. His parents and relatives did not have mucocutaneous pigmentation, but they had not been examined for malignancies by endoscopy.
MUTATION ANALYSIS
Blood samples were collected from the proband and his parents and, as controls, also from 50 unrelated healthy children (27 males, 23 females) who were all 6 years of age and who visited the outpatient section of the Department of Paediatrics, Affiliated Hospital of Guiyang Medical College for routine clinical examination. The study was performed according to the Declaration of Helsinki and approved by the Ethics Committee of the Affiliated Hospital of Guiyang Medical College. Written informed consent for sample collection and DNA examination was obtained from the parents of all 50 controls and from the proband's parents.
Genomic DNA was isolated from peripheral blood lymphocytes using standard procedures. All of the coding exons and exon-intron boundaries of STK11 were amplified by polymerase chain reaction (PCR) using standard designed primers and amplification conditions as described previously. 7, 12 The PCR was performed in a 50 µl reaction system containing 10 × PCR buffer, 0.1 mmol/l deoxyribonucleotide triphosphates, 20 mmol/l Mg 2+ , 200 ng genomic DNA, 10 pmol/µl of each sense and antisense primer and 1.25 U Taq DNA polymerase. The PCR products underwent gel electrophoresis for purification and direct sequencing using an ABI Prism™ 3730XL sequencer (Applied Biosystems, Carlsbad, CA, USA). Exon 5 was screened at the same time in samples from the patient, his parents and the 50 unrelated healthy control children.
RESULTS
Mutation analysis of the entire coding sequence of STK11 demonstrated that the proband had a heterozygous single base-pair insertion of guanine (G) between nucleotides 698 and 699 (c.698_699insG; F234LfsX3) in exon 5 of the STK11 gene (Fig. 2 ). This insertion would be expected to lead to a frameshift and to introduce a premature stop codon at codon 236. The mutation was not found in either parent, both of whom were clinically unaffected, or in chromosomes from the 50 healthy control children. This is a novel de novo mutation in the STK11 gene and has not been reported previously.
Discussion
The Chinese proband fulfilled the clinical criteria for diagnosis of PJS, including STK11 mutation in Peutz-Jeghers syndrome histopathologically verified hamartomatous polyps plus at least two of the following: small bowel polyposis; mucocutaneous melanotic pigmentation; and a family history of the disease. 13 Mutations in the STK11 gene on chromosome 19p13.3 have been identified previously as causing PJS. 6, 7 Previous studies have identified a causative mutation of STK11 in 30 -80% of PJS patients. 14 -18 Most STK11 mutations are small deletions/insertions or single-base substitutions resulting in an abnormal, truncated/kinase-inactive protein. The STK11 protein comprises three major domains: an N-terminal non-catalytic domain containing the nuclear localization signal; a catalytic kinase domain which is important for adenosine triphosphate binding; and a carboxyterminal noncatalytic regulatory domain containing a prenylation motif (CAAX box). Codons 49 -309 encode the catalytic kinase domain. The C-terminal non-catalytic region of the STK11 protein is encoded by exons 8 and 9 and encompasses amino acids 309 -433. 7 Although the exact function of STK11 remains unclear, it has been demonstrated that mutation of the STK11 gene leads to loss of kinase activity and that this loss of activity is probably responsible for the development of PJS. 19 There is evidence that STK11 mutations may contribute to tumourigenesis through various mechanisms, such as induction of angiogenesis, suppression of growth arrest, apoptosis and loss of cell polarity. 20 In the present sporadic case of PJS, a mutation (c.698_699insG; F234LfsX3) was identified in exon 5 of the STK11 gene. Study of the family constellation and unaffected control individuals indicated that this mutation arose de novo. It was located in the catalytic kinase domain within codons 49 -309 and was expected to result in an incomplete catalytic kinase domain, leading to inactivation of kinase activity and complete loss of the C-terminal domain.
Several authors have analysed genotypephenotype correlations in PJS. Individuals with mis-sense mutations had a significantly later time of first polypectomy and onset of various symptoms than people with either truncating mutations or no detectable mutation. 21 A possible trend to an earlier age of onset of intussusception has been seen in individuals with truncating mutations of STK11. 22 The proband of the present study, who had the truncating mutation c.698_699insG in exon 5 of the STK11 gene, developed rectal polyps at the age of 1.5 
• Received for publication 5 April 2011 • Accepted subject to revision 11 April 2011 • Revised accepted 20 June 2011 Copyright © 2011 Field House Publishing LLP years and intussusception at 6 years. He had a variety of pathological types of polyp coexisting at multiple sites, including specifically hamartomatous polyps. These clinical features may be associated with a specific genotype with a known increased risk of cancer in PJS. 20, 21 One study in 419 individuals with PJS found that the risk of developing any first cancer by age 20, 30, 40, 50, 60 and 70 years was 2%, 5%, 17%, 31%, 60% and 85%, respectively. 23 The risk for all cancers in the general population by age 70 years is approximately 18%, however the risk in PJS patients is increased approximately four-fold. There may be no significant correlation between the type or site of the STK11 mutation and the risk of cancer. 23 Mehenni et al. 24 found no statistically significant differences in the risk of cancer between familial and isolated PJS cases. A cancer surveillance system should, therefore, be formulated for patients with PJS.
In summary, this article reports the clinical and molecular characterization of a Chinese child with PJS. A novel de novo mutation (c.698_699insG; F234LfsX3) in exon 5 of STK11 was identified in this patient, thus enlarging the mutational spectrum of STK11. Molecular diagnosis will be an important help in genetic counselling, prenatal diagnosis and patient management. The results of this study may be useful in improving the precision of future genotype-phenotype correlation research.
